Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney diseaseDaniela Egli-Spichtig, Carsten A. Wagner, Hongbo Zhang et al.|Kidney International|2014Cited by 94
Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studySabrina Kuoni, Ana Paula Simões‐Wüst, Nicole Ochsenbein‐Kölble et al.|Biomedicine & Pharmacotherapy|2024Cited by 15